INDP NASDAQ
Indaptus Therapeutics, Inc.
1W: +11.8%
1M: +0.6%
3M: +81.9%
YTD: +20.8%
1Y: -8.8%
3Y: -95.4%
5Y: -98.5%
$3.31
-0.04 (-1.05%)
Weekly Expected Move ±25.1%
$2
$2
$3
$4
$5
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: no debt. Altman Z'' -6.32.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
8 relationships8
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2022-12-23
Earliest Filing
2025-02-12
Latest Filing
partner: 3
investor: 2
acquirer: 2
target: 1
Counterparties (Filed by INDP)
8 relationshipsCompanies named in INDP's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| YA II PN, LTD. | — | investor | Investor in the Standby Equity Purchase Agreement | 2025-02-12 | View |
| INDAPTUS THERAPEUTICS, INC. | INDP | target | Company issuing shares to the Investor | 2025-02-12 | View |
| Indaptus Therapeutics, Inc. | INDP | acquirer | Company entering into a placement agent agreement for a private placement of equity securities | 2024-11-22 | View |
| Paulson Investment Company, LLC | — | partner | Placement Agent engaged to assist in arranging the private placement of equity securities | 2024-11-22 | View |
| Indaptus Therapeutics, Inc | INDP | partner | Company issuing securities in the offering | 2024-08-08 | View |
| Paulson Investment Company, LLC | — | partner | Placement agent arranging the equity securities offering | 2024-08-08 | View |
| INDAPTUS THERAPEUTICS, INC. | INDP | acquirer | Company selling common stock to investor | 2022-12-23 | View |
| LINCOLN PARK CAPITAL FUND, LLC | — | investor | Investor purchasing up to $20,000,000 of common stock | 2022-12-23 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-20 | Other Events | View | |
| 2026-09-30 | Material Agreement; Exhibits | Agreement | View |
| 2026-09-10 | Material Agreement; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-09-08 | Material Agreement; Exhibits | Agreement | View |
| 2026-09-04 | Officer/Director Change; Exhibits | View | |
| 2026-09-01 | Material Agreement; Exhibits | Agreement | View |
| 2026-08-13 | Earnings Release; Shareholder Vote; Exhibits | View | |
| 2026-06-24 | Material Agreement; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-06-05 | Officer/Director Change; Exhibits | View | |
| 2026-05-15 | Earnings Release; Exhibits | View | |
| 2026-04-24 | Officer/Director Change; Exhibits | View | |
| 2026-04-23 | Officer/Director Change; Exhibits | View | |
| 2026-04-03 | Officer/Director Change; Exhibits | View | |
| 2026-03-24 | Change in Control; Officer/Director Change; Exhibits | View | |
| 2026-02-27 | Material Modification to Rights of Security Holders; Changes in Control of Registrant; Amendments to | View | |
| 2026-02-12 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2026-01-20 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2026-01-08 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2026-01-02 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-12-23 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Material Modifica | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR